ZILTIVEKIMAB
UNII AN3Y2B4SX4

Substance Identification & Data

This profile provides standardized clinical and technical data for Ziltivekimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AN3Y2B4SX4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2226654-05-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

AN3Y2B4SX4

CAS Registry Number

2226654-05-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZILTIVEKIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C171844

National Cancer Institute reference terminology for clinical and research data.

INN ID

11143

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-212

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ziltivekimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZILTIVEKIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (255-TYROSINE,257-THREONINE,259-GLUTAMIC ACID), ANTI-(HUMAN INTERLEUKIN 6) (HUMAN MONOCLONAL 2E2.3A9.6A3 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 2E2.3A9.6A3 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL6 (INTERLEUKIN 6, IL-6)), MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-450) (VH (HOMO SAPIENS IGHV3-66*01 (88.8%) -(IGHD) -IGHJ1*01 (90.9%)) (8.8.13) (1-120) -HOMO SAPIENS IGHG1*03 G1M3, NG1M1 (CH1 R120 (217) (121-218), HINGE 1-15 (219-233), CH2 M15.1>Y (255), S16>T (257), T18>E (259) (234-343), CH3 E12 (359), M14 (361) (344-448), CHS (449-450)) (121-450)), (223-213')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-213') (V-KAPPA (HOMO SAPIENS IGKV1-5*03 (96.7%) -IGKJ2*03 (100%)) (6.3.8) (1'-106') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (152), V101 (190) (107'-213')); DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO)-GS CELL LINE, GLYCOFORM ALFA

MEDI 5117 [WHO-DD]

ZILTIVEKIMAB [INN]

ZILTIVEKIMAB [USAN]

ZILTIVEKIMAB [WHO-DD]